Evidence map›Paper›PMID 21795043›Full record

ArticleBioorganic & medicinal chemistry letters2011

The Mycobacterium tuberculosis CysQ phosphatase modulates the biosynthesis of sulfated glycolipids and bacterial growth.

Stavroula K Hatzios, Michael W Schelle, Gerald L Newton, Kimberly M Sogi, Cynthia M Holsclaw, Robert C Fahey, Carolyn R Bertozzi

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stavroula K HatziosDepartment of Chemistry, Howard Hughes Medical Institute, University of California, Berkeley, CA 94720, USA.
Michael W Schelle
Gerald L Newton
Kimberly M Sogi
Cynthia M Holsclaw
Robert C Fahey
Carolyn R Bertozzi

Funding

Mycobacterial Sulfation PathwaysR01AI051622 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI BERTOZZI, CAROLYN · 2002 to 2015
$6.0M
Chemical MycobateriologyR37AI051622 · NIAID · STANFORD UNIVERSITY · PI BERTOZZI, CAROLYN · 2016 to 2025
$4.7M
Whole cell and essential enzyme screening assays for mycothiol biosynthesisR01AI072133 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FAHEY, ROBERT C · 2007 to 2009
$899k
Howard Hughes Medical InstituteNIAID NIH HHS AI51622NIAID NIH HHS AI72133NIAID NIH HHS R01 AI051622NIAID NIH HHS R01 AI072133NIAID NIH HHS R37 AI051622
6 · The paper itself

Abstract

CysQ is a 3'-phosphoadenosine-5'-phosphatase that dephosphorylates intermediates from the sulfate assimilation pathway of Mycobacterium tuberculosis (Mtb). Here, we demonstrate that cysQ disruption attenuates Mtb growth in vitro and decreases the biosynthesis of sulfated glycolipids but not major thiols, suggesting that the encoded enzyme specifically regulates mycobacterial sulfation.

Indexed as

Chromatography, LiquidGlycolipidsMycobacterium tuberculosisPhosphoric Monoester HydrolasesSulfatesGlycolipidsPhosphoric Monoester HydrolasesSulfates

Identifiers

PMID21795043
PMCPMC3184767

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.